Shenbin Xu

1.6k total citations · 2 hit papers
21 papers, 1.1k citations indexed

About

Shenbin Xu is a scholar working on Neurology, Immunology and Molecular Biology. According to data from OpenAlex, Shenbin Xu has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Shenbin Xu's work include Intracerebral and Subarachnoid Hemorrhage Research (7 papers), Intracranial Aneurysms: Treatment and Complications (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Shenbin Xu is often cited by papers focused on Intracerebral and Subarachnoid Hemorrhage Research (7 papers), Intracranial Aneurysms: Treatment and Complications (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Shenbin Xu collaborates with scholars based in China, United States and India. Shenbin Xu's co-authors include Jianmin Zhang, Jianan Lü, Anwen Shao, John H. Zhang, Ligen Shi, Jingwei Zheng, Yuanjian Fang, Shuhao Mei, Haijian Wu and Sheng Chen and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Advanced Science.

In The Last Decade

Shenbin Xu

20 papers receiving 1.1k citations

Hit Papers

Glial Cells: Role of the Immune Response in Ischemic Stroke 2020 2026 2022 2024 2020 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenbin Xu China 14 495 373 259 226 169 21 1.1k
Samuel Shi United States 17 531 1.1× 282 0.8× 390 1.5× 353 1.6× 185 1.1× 27 1.1k
Fang Yu United States 14 494 1.0× 263 0.7× 272 1.1× 285 1.3× 179 1.1× 17 992
Guiyun Cui China 19 346 0.7× 535 1.4× 156 0.6× 124 0.5× 202 1.2× 53 1.2k
Ana Moraga Spain 17 607 1.2× 391 1.0× 126 0.5× 356 1.6× 235 1.4× 29 1.3k
Shotaro Michinaga Japan 17 358 0.7× 345 0.9× 270 1.0× 86 0.4× 110 0.7× 35 966
Shangfeng Zhao China 13 391 0.8× 439 1.2× 116 0.4× 196 0.9× 133 0.8× 28 1.0k
Luokun Xie United States 14 483 1.0× 313 0.8× 106 0.4× 290 1.3× 128 0.8× 19 1.1k
Muyassar Mamtilahun China 16 538 1.1× 280 0.8× 105 0.4× 142 0.6× 68 0.4× 21 845
Yongjun Jiang China 19 344 0.7× 395 1.1× 124 0.5× 95 0.4× 169 1.0× 38 1.1k

Countries citing papers authored by Shenbin Xu

Since Specialization
Citations

This map shows the geographic impact of Shenbin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenbin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenbin Xu more than expected).

Fields of papers citing papers by Shenbin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenbin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenbin Xu. The network helps show where Shenbin Xu may publish in the future.

Co-authorship network of co-authors of Shenbin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shenbin Xu. A scholar is included among the top collaborators of Shenbin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenbin Xu. Shenbin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Shenbin, et al.. (2024). Prognostic effect of CEA, AFP, CA19‑9 and CA242 for recurrence/metastasis of gastric cancer following radical gastrectomy. Molecular and Clinical Oncology. 22(2). 17–17. 2 indexed citations
2.
Zheng, Jingwei, Haijian Wu, Xiaoyu Wang, et al.. (2023). Temporal dynamics of microglia-astrocyte interaction in neuroprotective glial scar formation after intracerebral hemorrhage. Journal of Pharmaceutical Analysis. 13(8). 862–879. 27 indexed citations
3.
Zhang, Anke, Qian Yu, Zelin Wang, et al.. (2023). Single‐Cell RNA Sequencing and Spatial Transcriptomics Reveal Pathogenesis of Meningeal Lymphatic Dysfunction after Experimental Subarachnoid Hemorrhage. Advanced Science. 10(21). e2301428–e2301428. 34 indexed citations
4.
Xu, Shenbin, Shuhao Mei, Jianan Lü, et al.. (2021). Transcriptome Analysis of Microglia Reveals That the TLR2/IRF7 Signaling Axis Mediates Neuroinflammation After Subarachnoid Hemorrhage. Frontiers in Aging Neuroscience. 13. 645649–645649. 12 indexed citations
5.
Wang, Yongjie, Buyi Zhang, Jianli Wang, et al.. (2021). Discovery of LAMP-2A as potential biomarkers for glioblastoma development by modulating apoptosis through N-CoR degradation. Cell Communication and Signaling. 19(1). 40–40. 13 indexed citations
6.
Zheng, Jingwei, Jianan Lü, Shuhao Mei, et al.. (2021). Ceria nanoparticles ameliorate white matter injury after intracerebral hemorrhage: microglia-astrocyte involvement in remyelination. Journal of Neuroinflammation. 18(1). 43–43. 91 indexed citations
7.
Xu, Shenbin, et al.. (2021). Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma. Frontiers in Oncology. 11. 729103–729103. 24 indexed citations
8.
Mei, Shuhao, Yuanjian Fang, Jianan Lü, et al.. (2021). The Changes of Leukocytes in Brain and Blood After Intracerebral Hemorrhage. Frontiers in Immunology. 12. 617163–617163. 30 indexed citations
9.
Wu, Haijian, Jingwei Zheng, Shenbin Xu, et al.. (2021). Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. Journal of Neuroinflammation. 18(1). 2–2. 228 indexed citations breakdown →
10.
Fang, Yuanjian, Shenbin Xu, Jianan Lü, et al.. (2020). Validation and Comparison of Aneurysmal Subarachnoid Hemorrhage Grading Scales in Angiogram‐Negative Subarachnoid Hemorrhage Patients. BioMed Research International. 2020(1). 9707238–9707238. 5 indexed citations
11.
Xu, Shenbin, Jianan Lü, Anwen Shao, John H. Zhang, & Jianmin Zhang. (2020). Glial Cells: Role of the Immune Response in Ischemic Stroke. Frontiers in Immunology. 11. 294–294. 436 indexed citations breakdown →
12.
Wang, Zhen, Jingyi Zhou, Feng Liang, et al.. (2020). Prognostic models for neurological functional outcomes in aneurysmal subarachnoid hemorrhage patients with intracranial hematoma. Clinical Neurology and Neurosurgery. 191. 105691–105691. 4 indexed citations
13.
Liang, Feng, Jianli Wang, Zhen Wang, et al.. (2020). <p>Melatonin Alleviates Neuronal Damage After Intracerebral Hemorrhage in Hyperglycemic Rats</p>. Drug Design Development and Therapy. Volume 14. 2573–2584. 12 indexed citations
14.
Lü, Jianan, Zeyu Sun, Yuanjian Fang, et al.. (2019). Melatonin Suppresses Microglial Necroptosis by Regulating Deubiquitinating Enzyme A20 After Intracerebral Hemorrhage. Frontiers in Immunology. 10. 1360–1360. 42 indexed citations
15.
Fang, Yuanjian, et al.. (2018). Mammalian Sterile20-like Kinases: Signalings and Roles in Central Nervous System. Aging and Disease. 9(3). 537–537. 24 indexed citations
16.
Shi, Ligen, et al.. (2017). Endovascular Treatment of Intracavernous Internal Carotid Aneurysm Secondary to Pituitary Infection. World Neurosurgery. 101. 816.e5–816.e9.
17.
Shi, Ligen, Keren Zhou, Anwen Shao, et al.. (2017). PCMT1 Ameliorates Neuronal Apoptosis by Inhibiting the Activation of MST1 after Subarachnoid Hemorrhage in Rats. Translational Stroke Research. 8(5). 474–483. 31 indexed citations
18.
Shi, Ligen, Shenbin Xu, Jingwei Zheng, Jing Xu, & Jianmin Zhang. (2017). Blood Pressure Management for Acute Intracerebral Hemorrhage: A Meta-Analysis. Scientific Reports. 7(1). 14345–14345. 20 indexed citations
19.
Wang, Zefeng, Ligen Shi, Shenbin Xu, & Jianmin Zhang. (2017). Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials. Drug Design Development and Therapy. Volume 11. 1273–1282. 14 indexed citations
20.
Shi, Ligen, et al.. (2016). Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials. Drug Design Development and Therapy. Volume 10. 3899–3907. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026